The antibiotic teixobactin—developed a decade ago by Northeastern University professors Kim Lewis and Slava Epstein in ...

Hypharm GmbH has presented data regarding their recombinant chimeric bacteriophage endolysin HY-133 for the potential treatment of MRSA infection. HY-133 targets S. aureus and its design combines the ...

With the rising prevalence of methicillin-resistant Staphylococcus (S.) aureus (MRSA), a multi drug resistant strain, treatment has become a ...

A newly developed laboratory tool can, within hours, help to identify specific viruses which can be used to destroy variants ...

The MRSA superbug has evolved into 'fitter' strains which could prove even more resistant to treatment, a leading scientist warned on Tuesday. Professor Hajo Grundmann, a world expert in ...

With the rising prevalence of methicillin-resistant Staphylococcus ( S .) aureus (MRSA), a multi drug resistant strain, ...

What are the treatments? The main antibiotic for treating MRSA patients has been vancomycin, but there have been reports of resistance and it can only be given intravenously. New antibiotics are ...

PINNEBERG, GERMANY / ACCESS Newswire / March 14, 2025 / Viromed Medical AG ("Viromed", Ticker:VMED; ISIN: DE000A3MQR65), a medical technology company and pioneer of cold plasma technology for ...

Medical honey proves effective against antibiotic-resistant bacteria, transforming wound care and offering hope in the fight ...